Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Ahren Innovation Capital is a venture capital firm based in the United Kingdom, founded to support companies at the intersection of deep technology and deep science. The firm has a combined technology valuation exceeding $100 billion among its founding and science partners. Ahren operates globally, with a strong emphasis on the UK market.
Ahren invests in deep technology across four domains: Brain & AI, Genetics & Platform Technologies, Space & Robotics, and Efficient Energy. They provide both patient and active capital to founders and teams at all stages, from pre-seed to pre-IPO, aiming to build companies and support high-growth businesses.
Ahren's portfolio includes notable companies such as Adrestia, acquired by Insmed for its work on genetic diseases; Mentee Robotics, which developed MenteeBot, a humanoid robot utilizing AI; and Constructive Bio, which raised $58 million in Series A financing.
Submit your pitch through their website's contact form at [URL] or email [address] with your deck for consideration.
Yes, Ahren often leads investment rounds, particularly in early-stage companies within their focus sectors.
Ahren is open to follow-on investments, especially for companies demonstrating significant growth and potential in their respective fields.
The specific size of Ahren's current fund is not publicly disclosed, but they have a substantial combined technology valuation of over $100 billion among partners.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.